Medtronic released Sugar.IQ in partnership with IBM Watson Health in June. The Sugar.IQ app, which is available to users of Medtronic’s Guardian Connect continuous glucose monitoring system via Apple’s App Store, uses artificial intelligence and analytics from IBM Watson Health to analyze how certain foods, insulin dosages and daily routines influence a user’s glucose levels.
The new feature — dubbed IQcast — predicts the likelihood of a user experiencing a low-glucose event up to four hours in advance, supporting Medtronic and IBM Watson Health’s goal of providing patients with personalized guidance to manage their diabetes.
“Simply put, IQcast acts like a weather forecast for people with diabetes so they can better prepare for their day,” said Robert Vigersky, MD, senior director of medical and clinical affairs for the diabetes group at Medtronic.
More articles on artificial intelligence:
Apple promotes AI chief to exec team: 4 things to know
AI can re-identify de-identified health data, study finds
NYU School of Medicine releases 10K MRI scans as part of Facebook collaboration
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
